Skip to content
Saturday, November 7, 2026
UpdateTechSite

The Zimbabwean Government Turns Down ‘Unbalanced’ US Health Aid Package Due to Data Concerns

Medical aid illustration
The offered American financial assistance would have supported programmes for treating and preventing HIV/Aids, TB, and malarial diseases.

Zimbabwe has turned down a significant American healthcare agreement worth $367m (272 million pounds) over five years over the United States' insistence on confidential biological samples.

This move was revealed following a internal memorandum from December was leaked, revealing that Head of State Emmerson Mnangagwa felt the arrangement was "skewed".

A government representative has since clarified that the US was requesting biological samples for research and commercial purposes while was unwilling to guarantee the resulting advantages from any future vaccines.

"We must now begin the challenging and unfortunate process of winding down our support in Zimbabwe," said US ambassador to Zimbabwe Pamela Tremont publicly.

Her embassy said the United States had provided more than $1.9bn in health funding to Zimbabwe over the last two decades.

A physicians' group in Zimbabwe has called for more dialogue to secure a deal acceptable to both sides so the nation's critical HIV programme can proceed.

Wider Background

This development comes after a similar case in neighbouring Kenya, where a court suspended a related deal with the US following concerns were filed about the security of Kenyans' medical information.

After returning to the presidency last year, US President Donald Trump has reduced foreign aid and shut down the key foreign aid agency.

USAID had overseen aid for the US government, but Trump claimed its expenditure was "inefficient" and his government was seeking government-to-government deals to enhance transparency and accountability.

As per statements, Sixteen nations in Africa have so far signed these new health pacts, constituting more than $18.3bn in new funding.

Specifics of the Rejected Deal

This assistance for Zimbabwe would have gone towards "tackling HIV/Aids, TB, malaria, healthcare for mothers and children, and preparing for epidemics".

"We believe this cooperation might have yielded immense benefits for Zimbabwean communities, especially the 1.2 million currently receiving antiretroviral therapy through US-supported initiatives," the Ambassador added.

However, government spokesperson Nick Mangwana argued the proposed deal was "unfair".

"The proposal required Zimbabwe to share its genetic material and health information for a long time, with no equivalent promise of benefiting from any medical innovations – such as vaccines, diagnostics, or treatments – that might result from that shared data," Mangwana explained.

"Put simply, our country would provide the basic resources for scientific discovery without any certainty that the resulting innovations would be available to our population should a future disease outbreak emerge."

Sovereignty and Global Health

Mangwana further noted that the American exit from the World Health Organization (WHO) and its pursuit of bilateral deals were undermining frameworks already established via the international organization.

The spokesperson gave as an example its Pathogen Access and Benefit Sharing system created to deal with future global health emergencies.

"This mechanism is intended to guarantee that when a country contributes its data, the benefits – such as vaccines and treatments – are shared equitably, not commercialised solely by those with the capability to develop them."

The government's concerns over the US deal "must not be interpreted as opposition to America," he added.

"We welcome further discussions with our US partners on how subsequent co-operation might be structured in a manner that respects the sovereignty and dignity of each country."

Medical Community Response

The Zimbabwe College of Public Health Physicians (ZCPHP) said it understood the government's concerns, but recommended that negotiations need to persist since a large portion of the nation's Aids initiatives were funded by foreign aid.

"If specific concerns arise, including those involving data governance or agreement terms, these can frequently be addressed via detailed discussion and negotiated safeguards," the group said.

The situation underscores the continuing debate between receiving much-needed international aid and protecting a country's data in an ever more data-driven world.

Written by

Matthew Barrett

A tech journalist with over a decade of experience covering emerging technologies and digital trends across Europe.

UpdateTechSite

Type to search articles.